BMANA Journal of BMANA Journal of BMANA Journal of BMANA 2231-2196 0975-5241 82 Medical Association Uncovering an Uncommon Outcome: A Case Report of Colchicine-Induced Aplastic Anemia 24 07 2023 2 1 1 7 This article is copyright of Popeye Publishing, 2009 2009 This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.

Aplastic anemia because of immunosuppressive drugs such as Colchicine is a rare consequence of a commonly prescribed treatment for various common diseases such as gout. It is crucial to have a high clinical suspicion of aplastic anemia when a patient who has recently started Colchicine presents with nonspecific symptoms such as fatigue, weakness, or recurrent infections. This is a unique case of a 68-year-old African American female who presented with persistent fatigue, generalized weakness, and dizziness upon standing that began approximately 3 months following the initiation of Colchicine for a new diagnosis of gout.